13 results
Diffuse large B cell lymphoma (DLBCL) - Management and Treatment Algorithm

By Matthew Ho, MD PhD @MatthewHoMD

#Diffuse
Diffuse large B ... and Treatment Algorithm ... MatthewHoMD #Diffuse ... #Treatment #Algorithm ... #oncology #hematology
Hepatitis B Management in Cancer

DOI: 10.1200/JCO.20.01757

#HepatitisB #HBV #HepBV #Management #Cancer #oncology #hepatology #algorithm
Hepatitis B Management ... in Cancer DOI: ... HepatitisB #HBV #HepBV #Management ... #Cancer #oncology ... #hepatology #algorithm
Causes of Diffuse and Localized Lymphadenopathy - Differential Diagnosis Algorithm
 • Reactive (Inflammatory / Infectious)
 •
Causes of Diffuse ... and Localized Lymphadenopathy ... Metastatic) #Diffuse ... #Causes #Hematology ... #Oncology
US Preventive Services Task Force - Prostate Cancer Screening - Update 2018
Patient Decision Aid

 - Men
Services Task Force - Prostate ... Cancer Screening ... Aid - Men aged ... cancer in men 70 ... #Management #Urology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
incidental DVT or PE in cancer ... thrombosis in cancer ... †The decision to ... #Management #Hematology ... #Oncology
Early Breast Cancer - Management Algorithm
 • Luminal A-like (ER+ and/or PR+, HER2- and low proliferation)
Early Breast Cancer ... - Management Algorithm ... Early #Breast #Cancer ... #Management #Algorithm ... #treatment #oncology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... Currently, edoxaban and ... #Algorithm #Anticoagulation ... #Management #Hematology ... #Oncology
â–º
Summary of types of haemolytic anaemia. Visit gramproject.com for more medical diagrams, tables and flowcharts for
your learning, revision ... and teaching. ... diagnosis #clinical #management ... #differential #algorithm ... #anaemia #haematology
Post-Transplantation Lymphoproliferative Disorders (PTLD)
Definition: Lymphoid and/or plasmacytic proliferations that occur as a result of immunosuppression in
for 21% of all cancers ... 4% among women and ... symptoms, unexplained hematologic ... Lymphoproliferative #Disorders #oncology ... #diagnosis #management
Melanoma Treatment Algorithm

Resectable vs Inoperable Disease

Matthew Ho, MD PhD @MatthewHoMD and Aakash Desai, MD @ADesaiMD

#Melanoma #Treatment
Melanoma Treatment Algorithm ... PhD @MatthewHoMD and ... Melanoma #Treatment #Algorithm ... #Management #dermatology ... #oncology